Giugliano D, Torella R, Improta L, D'Onofrio F
Diabete Metab. 1978 Sep;4(3):187-91.
The influence of prostaglandin E1 and prostaglandin F2alpha on circulating concentrations of insulin and glucagon during the intravenous glucose tolerance test has been studied in normal man. Insulin responses to glucose during PGE1 infusion (0.2 microgram/Kg/min) were significantly lower than in control infusions (p less than 0.001 at 2, 5, 10 and 15 min). Moreover, PGE1 caused a clear elevation of basal glucagon (p less than 0.02). PGF2alpha, at the two doses used (0.2 and 0.5 microgram/Kg/min), had no effect on basal glucose, insulin and glucagon levels, nor upon glucose-induced insulin secretion. Neither prostaglandin affected the glucose-induced inhibition of pancreatic alpha-cells. There is thus some evidence that PGs of E series may play some role in modulating the secretion of human pancreatic beta-cells.
在正常男性中研究了前列腺素E1和前列腺素F2α对静脉葡萄糖耐量试验期间胰岛素和胰高血糖素循环浓度的影响。在输注前列腺素E1(0.2微克/千克/分钟)期间,对葡萄糖的胰岛素反应明显低于对照输注(在2、5、10和15分钟时p<0.001)。此外,前列腺素E1导致基础胰高血糖素明显升高(p<0.02)。所使用的两种剂量(0.2和0.5微克/千克/分钟)的前列腺素F2α对基础葡萄糖、胰岛素和胰高血糖素水平以及葡萄糖诱导的胰岛素分泌均无影响。两种前列腺素均不影响葡萄糖诱导的胰腺α细胞抑制。因此,有一些证据表明E系列前列腺素可能在调节人胰腺β细胞分泌中起一定作用。